IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Clinical trials for IMMUNOGLOBULIN A (IGA) NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN A (IGA) NEPHROPATHY trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN A (IGA) NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients: drug targets protein spill in kidneys
Disease control Recruiting nowThis study tests a drug called sparsentan in 20 adults who have had a kidney transplant and still have protein in their urine due to IgA nephropathy or FSGS. The goal is to see if the drug can safely reduce protein levels over 36 weeks. Participants take one pill daily, and the s…
Matched conditions: IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Phase: PHASE4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
Gene therapy trial aims to halt kidney disease in High-Risk patients
Disease control Recruiting nowThis study tests a new gene therapy called PS-002 for adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The treatment is given once and aims to control the disease in people who are at high risk of getting worse despite current treatments. The study w…
Matched conditions: IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Purespring Therapeutics Limited • Aim: Disease control
Last updated May 04, 2026 16:20 UTC